Literature DB >> 28881885

IgG4-related disease involving the esophagus: a clinicopathological study.

I Obiorah1, A Hussain2, C Palese2, N Azumi1, S Benjamin2, M Ozdemirli1.   

Abstract

Immunoglobulin G4 (IgG4)-related disease is a recently coined systemic disease characterized by specific histopathologic findings of an intense lymphoplasmacytic infiltrate, storiform fibrosis, and obliterative phlebitis in the presence of predominant IgG4-positive plasma cells. Although IgG4-related disease has been described in many organs, involvement of the esophagus is very rare. In this study, we describe the clinicopathologic characteristics of eight patients with IgG4-related esophagitis. We evaluated chronic esophagitis specimens with lymphoplasmacytic infiltrate obtained over the past 6 years (from January 2011 to February 2017) using a chart review, pathologic examination, and IgG4 immunohistochemical staining. The diagnoses of the specimens were either confirmed as IgG4-related esophagitis (IgG4-RE) or chronic esophagitis, not otherwise specified (CENOS), and the clinicopathologic data from each group were compared. Eight patients were diagnosed with IgG4-RE and 10 controls were identified and diagnosed with CENOS. In the IgG4-RE group, esophageal strictures were identified in three patients, two patients had postmyotomy treated achalasia, one patient had erosive esophagitis and another presented with an esophageal nodule. Only one patient had an unremarkable mucosa on endoscopy. In the CENOS group, four patients had esophageal strictures, six had erosive esophagitis, one patient had mild esophagitis. The IgG4-RE group had significantly higher numbers of IgG4-positive plasma cells (66.9 ± 21.9 vs. 4.7 ± 2.4 per high power field; P< 0.001) and a greater IgG4: IgG ratio 0.76 ± 0.13 vs. 0.06 ± 0.05; P< 0.001) when compared to CENOS patients. Two of the patients with recurrent esophageal strictures in the IgG4-RE group showed initial response to steroid therapy and are currently on immunosuppressive therapy which has significantly reduced the need for multiple esophageal dilatations. The presentation of IgG4-related esophageal disease can vary and the key to diagnosis is dependent on histopathology. These observations highlight the need for IgG4 immunohistochemical staining of esophageal biopsies especially in patients with mucosal ulceration, chronic inflammation, and plasmacytosis on biopsy. This will prevent unwarranted esophagectomies and failed medical treatment due to lack of recognition of this entity.
© The Authors 2017. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  autoimmune; endoscopy; esophagus; gG4; immunohistochemistry

Mesh:

Substances:

Year:  2017        PMID: 28881885     DOI: 10.1093/dote/dox091

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  9 in total

1.  Esophageal IgG4 levels correlate with histopathologic and transcriptomic features in eosinophilic esophagitis.

Authors:  C E Rosenberg; M K Mingler; J M Caldwell; M H Collins; P C Fulkerson; D W Morris; V A Mukkada; P E Putnam; T Shoda; T Wen; M E Rothenberg
Journal:  Allergy       Date:  2018-06-17       Impact factor: 13.146

2.  European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations.

Authors:  J-Matthias Löhr; Ulrich Beuers; Miroslav Vujasinovic; Domenico Alvaro; Jens Brøndum Frøkjær; Frank Buttgereit; Gabriele Capurso; Emma L Culver; Enrique de-Madaria; Emanuel Della-Torre; Sönke Detlefsen; Enrique Dominguez-Muñoz; Piotr Czubkowski; Nils Ewald; Luca Frulloni; Natalya Gubergrits; Deniz Guney Duman; Thilo Hackert; Julio Iglesias-Garcia; Nikolaos Kartalis; Andrea Laghi; Frank Lammert; Fredrik Lindgren; Alexey Okhlobystin; Grzegorz Oracz; Andrea Parniczky; Raffaella Maria Pozzi Mucelli; Vinciane Rebours; Jonas Rosendahl; Nicolas Schleinitz; Alexander Schneider; Eric Fh van Bommel; Caroline Sophie Verbeke; Marie Pierre Vullierme; Heiko Witt
Journal:  United European Gastroenterol J       Date:  2020-06-18       Impact factor: 4.623

Review 3.  IgG4-related diseases of the digestive tract.

Authors:  J-Matthias Löhr; Miroslav Vujasinovic; Jonas Rosendahl; John H Stone; Ulrich Beuers
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-11-08       Impact factor: 46.802

Review 4.  Eosinophilic Esophagitis and IgG4: Is There a Relationship?

Authors:  Amanda H Lim; Stephanie Wong; Nam Q Nguyen
Journal:  Dig Dis Sci       Date:  2021-02-03       Impact factor: 3.199

5.  Use of tunnel endoscopy for diagnosis of obscure submucosal esophageal adenocarcinoma: A case report and review of the literature with emphasis on causes of esophageal stenosis.

Authors:  Song Liu; Nian Wang; Jian Yang; Jia-Yao Yang; Zhao-Hong Shi
Journal:  World J Clin Cases       Date:  2019-03-06       Impact factor: 1.337

6.  IgG4-Related Disease with Esophageal Involvement.

Authors:  Sung Wook Jang; Min Ho Jeon; Hyun Deok Shin
Journal:  Case Rep Gastroenterol       Date:  2019-09-12

7.  The Clinicopathologic Spectrum of IgG4-Related Disease

Authors:  Ifeyinwa Emmanuela Obiorah; Alicia Henao Velasquez; Metin Özdemirli
Journal:  Balkan Med J       Date:  2018-06-05       Impact factor: 2.021

Review 8.  Steroid Therapy and Steroid Response in Autoimmune Pancreatitis.

Authors:  Hiroyuki Matsubayashi; Hirotoshi Ishiwatari; Kenichiro Imai; Yoshihiro Kishida; Sayo Ito; Kinichi Hotta; Yohei Yabuuchi; Masao Yoshida; Naomi Kakushima; Kohei Takizawa; Noboru Kawata; Hiroyuki Ono
Journal:  Int J Mol Sci       Date:  2019-12-30       Impact factor: 5.923

Review 9.  Autoimmune Diseases of Digestive Organs-A Multidisciplinary Challenge: A Focus on Hepatopancreatobiliary Manifestation.

Authors:  Lumir Kunovsky; Petr Dite; Petr Jabandziev; Zdenek Kala; Jitka Vaculova; Tomas Andrasina; Matej Hrunka; Martina Bojkova; Jan Trna
Journal:  J Clin Med       Date:  2021-12-11       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.